GB883324A - New benzoxazine derivatives, their preparation and pharmaceutical compositions containing them - Google Patents

New benzoxazine derivatives, their preparation and pharmaceutical compositions containing them

Info

Publication number
GB883324A
GB883324A GB258/60A GB25860A GB883324A GB 883324 A GB883324 A GB 883324A GB 258/60 A GB258/60 A GB 258/60A GB 25860 A GB25860 A GB 25860A GB 883324 A GB883324 A GB 883324A
Authority
GB
United Kingdom
Prior art keywords
formula
alkyl
acid
dihydro
reacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB258/60A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of GB883324A publication Critical patent/GB883324A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/361,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

The invention comprises compounds of the general formula <FORM:0883324/IV (b)/1> in which R is hydrogen or a lower alkyl radical (i.e. containing less than four carbon atoms), R1 is hydrogen or a lower alkyl or lower alkoxy radical, R11 is hydrogen, an acyl group or a lower alkyl radical, together with processes for their preparation (a) by reacting a 2,2-dihalo-3-oxo-dihydro-1,4-benzoxazine with a compound of formula <FORM:0883324/IV (b)/2> (which is unsubstituted in the position para to OR11, and in which R1 and R11 are as defined above), any free OH groups being alkylated or acylated if desired during or after the reaction; (b) by reacting an a ,a -disubstituted glycollic acid of formula <FORM:0883324/IV (b)/3> (R111 is alkyl, aralkyl or other group which can be replaced by hydrogen) or a reactive ester thereof with an R-substituted o-aminophenol, and if necessary subsequently converting R111 into R11; (c) by ring closure of an a ,a -disubstituted glycollic acid o-hydroxyanilide of formula <FORM:0883324/IV (b)/4> The intermediate anilides are prepared by reaction of an R-substituted 2,3-dioxo-dihydro-1,4-benzoxazine with an organomagnesium halide of formula <FORM:0883324/IV (b)/5> or by reaction of an o-hydroxyphenyl oxamic acid ester of formula <FORM:0883324/IV (b)/6> (COOA is a reactive ester group) with the above Grignard reagent, or by reacting an a ,a -disubstituted-a -halo-acetyl halide corresponding to the glycollic acid V with an R-substituted o-aminophenol. The intermediate 2,2 - dihalo - 3 - oxo - dihydro-1,4-benzoxazines are prepared by halogenation of an R-substituted-2,3-dioxo-dihydro-1,4-benzoxazine. The oxamic acid esters are prepared by reacting an oxalic acid alkyl ester chloride with an o-aminophenol. a -Chloro-a ,a -bis (p-methoxyphenol) acetyl chloride is prepared from p-anisilic acid and PCl5.ALSO:Pharmaceutical compositions having laxative properties comprise benzoxazines of formula <FORM:0883324/VI/1> (in which R represents H or alkyl, R1 is H, alkyl or alkoxy and R11 is H, acyl or alkyl, the alkyl and alkoxy groups containing from one to three carbon atoms) together with a carrier. The compositions may take the form of tablets, dragees, emulsions, suspensions, granulates, suppositories and examples detail the formation of compositions of each type.
GB258/60A 1959-01-12 1960-01-04 New benzoxazine derivatives, their preparation and pharmaceutical compositions containing them Expired GB883324A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE883324X 1959-01-12

Publications (1)

Publication Number Publication Date
GB883324A true GB883324A (en) 1961-11-29

Family

ID=6831976

Family Applications (1)

Application Number Title Priority Date Filing Date
GB258/60A Expired GB883324A (en) 1959-01-12 1960-01-04 New benzoxazine derivatives, their preparation and pharmaceutical compositions containing them

Country Status (1)

Country Link
GB (1) GB883324A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9101634B2 (en) 2010-05-20 2015-08-11 Shandong University Application of 2, 3-dihydro-3-hydroxymethyl-6-amino-[1,4]-benzoxazine in preparation of drugs inducing embryonic stem cells to differentiate to vascular endothelial cells
US9187439B2 (en) 2011-09-21 2015-11-17 Inception Orion, Inc. Tricyclic compounds useful as neurogenic and neuroprotective agents

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9101634B2 (en) 2010-05-20 2015-08-11 Shandong University Application of 2, 3-dihydro-3-hydroxymethyl-6-amino-[1,4]-benzoxazine in preparation of drugs inducing embryonic stem cells to differentiate to vascular endothelial cells
US9187439B2 (en) 2011-09-21 2015-11-17 Inception Orion, Inc. Tricyclic compounds useful as neurogenic and neuroprotective agents

Similar Documents

Publication Publication Date Title
GB883324A (en) New benzoxazine derivatives, their preparation and pharmaceutical compositions containing them
GB1145904A (en) Disperse anthraquinone dyestuffs
ES399064A1 (en) Diazepine derivatives and process for their production
ES418827A1 (en) 2-aminoindane derivatives
GB974147A (en) New steroid compounds and processes
GB824536A (en) Improvements in or relating to new phenthiazine derivatives and processes for their preparation
ES448629A1 (en) Benzoxazole derivatives, process for their preparation and their use as optical brighteners
GB823191A (en) New phenthiazine derivatives and processes for their preparation
US2878256A (en) Tri-cyclohexyl borates
US3142675A (en) Novel derivatives of 3-carboxybenzothiazolenylbenzothiazolylalkane
US2792388A (en) Process for preparing nu-monoacylated glucosamine
GB1061946A (en) Novel dibenzocycloheptene derivatives and a process for the manufacture thereof
GB874575A (en) New basic ethers and a process for the production thereof
US2623045A (en) N-(substituted-aminoethyl) 4-aminobenzoic acid diethylaminoethyl esters
US2921953A (en) New substituted amino acid compounds and their preparation
GB852974A (en) Ethers and means for producing the same
US2425221A (en) Production of amidine salts
GB1321329A (en) Piperidine process and intermediates therefor
GB1118307A (en) Improvements in or relating to antibiotic derivatives and the manufacture thereof
GB1021390A (en) New derivatives of 16ª‡-ethynyl-19-nor-androst-1,3,5(10)-triene, pharmaceutical compositions thereof and processes for their preparation
GB1467225A (en) 7-alkoxy-4,6-dihydroxy-quinoline derivatives and pharmaceuti cal compositions thereof
ES262952A1 (en) 1 substituted isatin- -thiosemicarbazones,their preparation and pharmaceutical preparations containing them
GB701741A (en) Improvements in or relating to the preparation of phenthiazine derivatives
GB877358A (en) Improvements in or relating to caffeine-(8)-alkanolamines and their derivatives
GB712728A (en) Process for the production of new thioethers